Surveillance of Amoebic Keratitis-Causing Acanthamoebae for Potential Bacterial Endosymbionts in Ontario, Canada
- PMID: 35745515
- PMCID: PMC9230791
- DOI: 10.3390/pathogens11060661
Surveillance of Amoebic Keratitis-Causing Acanthamoebae for Potential Bacterial Endosymbionts in Ontario, Canada
Abstract
Acanthamoeba spp. are the causative pathogens of several infections, including amoebic keratitis (AK), a vision-threatening infection. Acanthamoebae from corneal specimens of patients with AK harbor bacterial endosymbionts, which may increase virulence. We sought to understand the spectrum of bacterial endosymbionts present in clinical isolates of Acanthamoeba spp. identified in our reference parasitology laboratory. Isolates of Acanthamoeba spp. obtained from our biobank of anonymized corneal scrapings were screened for potential endosymbionts by PCR using primer pairs detecting bacteria belonging to orders Chlamydiales, Rickettsiales, or Legionellales and pan16S primers. Three primer pairs specific to the 18s rRNA gene of Acanthamoeba spp. were used for the amplification of Acanthamoeba DNA used for sequencing. Sanger sequencing of all PCR products was performed, followed by BLAST analysis for species identification. We screened 26 clinical isolates of Acanthamoeba spp. for potential endosymbionts. Five isolates (19%) were found to contain bacterial DNA belonging to Legionellales. Three (11%) contained members of the Rickettsiales and Pseudomonas genticulata was detected in a Rickettsia-positive sample. One strain (4%) contained Neochlamydia hartmannellae, a member of the Chlamydiales order. Bacterial endosymbionts are prevalent in clinical strains of Acanthamoeba causing AK isolated from corneal scrapings. The demonstration of these organisms in clinical Acanthamoeba isolates supports a potential exploration of anti-endosymbiont therapeutics as an adjuvant therapy in the treatment of AK.
Keywords: Acanthamoeba; amoebic keratitis; endosymbionts; surveillance.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
Similar articles
-
Azithromycin and Doxycycline Attenuation of Acanthamoeba Virulence in a Human Corneal Tissue Model.J Infect Dis. 2017 Apr 15;215(8):1303-1311. doi: 10.1093/infdis/jiw410. J Infect Dis. 2017. PMID: 27578848
-
Detection of bacterial endosymbionts in clinical acanthamoeba isolates.Ophthalmology. 2010 Mar;117(3):445-52, 452.e1-3. doi: 10.1016/j.ophtha.2009.08.033. Epub 2010 Jan 19. Ophthalmology. 2010. PMID: 20031220 Free PMC article.
-
Occurrence of bacterial endosymbionts in Acanthamoeba spp. isolated from corneal and environmental specimens and contact lenses.J Clin Microbiol. 1993 May;31(5):1122-6. doi: 10.1128/jcm.31.5.1122-1126.1993. J Clin Microbiol. 1993. PMID: 8501212 Free PMC article.
-
[Acanthamoeba keratitis].J Fr Ophtalmol. 2014 Oct;37(8):640-52. doi: 10.1016/j.jfo.2014.05.004. Epub 2014 Aug 29. J Fr Ophtalmol. 2014. PMID: 25169145 Review. French.
-
New Frontiers in Acanthamoeba Keratitis Diagnosis and Management.Biology (Basel). 2023 Dec 5;12(12):1489. doi: 10.3390/biology12121489. Biology (Basel). 2023. PMID: 38132315 Free PMC article. Review.
References
-
- Clarke D.W., Niederkorn J.Y. The pathophysiology of Acanthamoeba keratitis. [(accessed on 28 May 2022)];Trends Parasitol. 2006 22:175–180. Available online: http://www.ncbi.nlm.nih.gov/pubmed/16500148. - PubMed
-
- Horn M., Wagner M. Bacterial endosymbionts of free-living amoebae. [(accessed on 28 May 2022)];J. Eukaryot. Microbiol. 2004 51:509–514. Available online: http://www.ncbi.nlm.nih.gov/pubmed/15537084. - PubMed
-
- Horn M., Fritsche T.R., Linner T., Gautom R.K., Harzenetter M.D., Wagner M. Obligate bacterial endosymbionts of Acanthamoeba spp. related to the -Proteobacteria: Proposal of “Candidatus Procabacter acanthamoebae” gen. nov., sp. nov. Int. J. Syst. Evol. Microbiol. 2002;52:599–605. doi: 10.1099/00207713-52-2-599. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous